56 results
8-K
EX-99.1
IDYA
Ideaya Biosciences Inc
20 Feb 24
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023
6:07am
of $323.3 million from underwritten public follow-on offerings completed in April and October 2023 partially offset by cash used in operations.
Subsequent
424B5
8c2aa9 5uqij
25 Oct 23
Prospectus supplement for primary offering
9:45pm
424B5
r9d5myqs2ph 57pgia
24 Oct 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
mykzk04ubadwwb4pvevy
10 Aug 23
IDEAYA Biosciences, Inc. Reports Second Quarter 2023
6:01am
424B5
dv9u54 3kbsz2znr9o
26 Jun 23
Prospectus supplement for primary offering
5:30pm
8-K
EX-99.1
35aa6kzju0q
9 May 23
IDEAYA Biosciences, Inc. Reports First Quarter 2023 Financial Results
6:01am
424B5
05ma ficb
25 Apr 23
Prospectus supplement for primary offering
7:35pm
424B5
1z6dm0t4se akfb
24 Apr 23
Prospectus supplement for primary offering
4:53pm
8-K
EX-99.1
t329sdqryw85way9y 53
8 Nov 22
IDEAYA Biosciences, Inc. Reports Third Quarter 2022
6:02am
424B5
zty2i
15 Sep 22
Prospectus supplement for primary offering
5:03pm
424B5
92budzmfr
14 Sep 22
Prospectus supplement for primary offering
5:01pm